{"name":"Val Lowe","slug":"val-lowe","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE9pY3NqQmYtQkFSWmoyMnBJbktYWlhDaVF0V0ltTnFUX3J4SXhGaXNjazRJY3BHcDB0Y2o3Yml2eDUyS3VCbHRiRWYzaEYtMkVfYlI2bjNhdkhQNkVYejBRSXlTdnZCV3NaTnFzTWZGWDkxSUdJ?oc=5","date":"2025-08-19","type":"trial","source":"Wiley","summary":"18F‐FDG PET in detection of primary age‐related tauopathy (PART) – Is there a role? Insights from an imaging‐pathology correlation study - Wiley","headline":"18F‐FDG PET in detection of primary age‐related tauopathy (PART) – Is there a role? Insights from an imaging‐pathology c","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE9YekZLdjF3S3MweGF2RWQwR3IzellXVDBEVHo3WmtUX2xKZTgxOHpuN2Q5SmQwdVhkbVNPYUItRDRoNGwtZjNPNVBZeHZWWlFSSnJUT0tmbG8?oc=5","date":"2024-05-23","type":"trial","source":"jnm.snmjournals.org","summary":"Patterns of Early Neocortical Amyloid-β Accumulation: A PET Population-Based Study - jnm.snmjournals.org","headline":"Patterns of Early Neocortical Amyloid-β Accumulation: A PET Population-Based Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1zYlUtekNJRkhBNW9rUUxnLW80QUhOTy1HQUlKeGk0SkR0cVRiaUN5YUM0THZqUUlmcXltNXZZSFVpY0p5c0lCMDQ4Rm1oTW1WWGtQRENua0hrelZaYzFhSGNR?oc=5","date":"2024-04-25","type":"pipeline","source":"jnm.snmjournals.org","summary":"Evaluation of Neurodegenerative Disorders with Amyloid-β, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls - jnm.snmjournals.org","headline":"Evaluation of Neurodegenerative Disorders with Amyloid-β, Tau, and Dopaminergic PET Imaging: Interpretation Pitfalls","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1Jb184SktjUTIxTHV5VkNYdjV1VG5wNkFhWXJQcFhZbUVPc1RNTDgwLUxzdGRzcWc0MTNCbG8waEoyaHpTUmpIc1RReFlRbnpZd19hRXlxbi1fcGFtS2VF?oc=5","date":"2018-05-09","type":"pipeline","source":"Nature","summary":"Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values - Nature","headline":"Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}